Newsroom

Industry News

22 Jul

Cytori to Webcast Second Quarter Financial Results on August 4

SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (CYTX) will provide a live webcast of its second quarter financial results and business update on Thursday, August 4, 2016 at 5:30 PM Eastern Time. The dial-in information is as follows: Dial-In Number: +1.877.402.3914 Conference ID: 54687177 Prior to the webcast at approximately...

Read more

21 Jul

MTBC to Announce Q2 2016 Financial Results on August 11, 2016

SOMERSET, NJ–(Marketwired – Jul 21, 2016) – MTBC ( NASDAQ : MTBC ) ( NASDAQ : MTBCP ), a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced that the company will release financial results for its quarter ended June 30, 2016 before the market opens on Thursday, August 11, 2016. MTBC will...

Read more

20 Jul

Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations

MADISON, Wis., July 20, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB) (“the company”), an oncology-focused biotechnology company, today announces the appointment of Jarrod Longcor as senior vice president of corporate development and operations, effective July 15, 2016. “Jarrod is an industry veteran who has spent considerable time creating...

Read more

20 Jul

Actinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial

NEW YORK, NY –(Marketwired – July 20, 2016) – Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or the “Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that the Company conducted a successful investigator meeting on July 15 – 16, 2016 in Dallas, Texas. The...

Read more

19 Jul

Moleculin Announces Successful Engineering Run for Production of Annamycin

HOUSTON, TX –(Marketwired – July 19, 2016) – Moleculin Biotech, Inc., (MBRX)(“Moleculin” or the “Company”), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today...

Read more

19 Jul

Onconova Announces Enrollment of First Patient in Japan by SymBio

NEWTOWN, Pa., July 19, 2016 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the enrollment of the first patient in Japan by SymBio Pharmaceuticals in the global Phase 3 INSPIRE trial, investigating...

Read more

19 Jul

Cytori Cell Therapy™ Phase I Trial Reports Maxillofacial Bone Regeneration

SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (CYTX) announced today the publication of the results from an investigator-initiated Phase I trial using Cytori Cell Therapy in patients with insufficient maxillary bone prior to dental implantation. The publication reported approximately 42% greater bone formation in maxillary sinus floor elevation (MSFE) procedures...

Read more

18 Jul

Champions Oncology Successfully Delivers First AML Study

HACKENSACK, N.J., July 18, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the successful completion of its first study in acute myeloid leukemia (AML).  Champions...

Read more

Page 1 of 17012345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address